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Summary
 
The involvement of chemokines in inflammation is well established, but their functional role
in disease progression, and particularly in the development of fibrosis, is not yet understood. To
investigate the functional role that the chemokines monocyte chemoattractant protein–1
(MCP-1) and RANTES play in inflammation and the progression to fibrosis during crescentic
nephritis we have developed and characterized a murine model for this syndrome. Significant
increases in T-lymphocytes and macrophages were observed within glomeruli and interstitium,
paralleled by an induction of mRNA expression of MCP-1 and RANTES, early after disease
initiation. Blocking the function of MCP-1 or RANTES resulted in significant decreases in
proteinuria as well as in numbers of infiltrating leukocytes, indicating that both MCP-1 and
RANTES (regulated upon activation in normal T cells expressed and secreted) play an impor-
tant role in the inflammatory phase of crescentic nephritis. In addition, neutralization of MCP-1
resulted in a dramatic decrease in both glomerular crescent formation and deposition of type I
collagen. These results highlight a novel role for MCP-1 in crescent formation and develop-
ment of interstitial fibrosis, and indicate that in addition to recruiting inflammatory cells this
chemokine is critically involved in irreversible tissue damage.
 
R
 
apidly progressive glomerulonephritis (GN)
 
1
 
 is char-
acterized by glomerular inflammation and the forma-
tion of glomerular crescents, composed of a pleiomorphic
infiltrate of mononuclear inflammatory cells and proliferat-
ing parietal epithelial cells. These crescents encroach on the
urinary space and compress the glomerular tuft causing
acute renal failure. This process is almost always associated
with severe interstitial and periglomerular inflammation.
Spontaneous recovery is rare. More typically, the inflam-
matory infiltrate gives way to a progressive fibrotic process
involving the crescents and the periglomerular and peritu-
bular interstitium, accompanied by tubular atrophy and
progressive renal failure. Indeed, clinical studies of patients
with glomerular diseases have shown a close correlation be-
tween the degree of interstitial fibrosis and the likelihood of
chronic renal failure (1, 2).
Although the pathogenesis of crescentic glomerulonephri-
tis is incompletely understood and likely involves several
convergent pathways, there is general agreement that circu-
lating mononuclear phagocytes play a central role (3, 4). Ad-
ministration of nephrotoxic serum to rats results in a severe
proliferative and necrotizing GN that is characterized by
glomerular crescent formation and accumulation of leuko-
cytes (5). These infiltrating cells may then release inflam-
matory mediators that influence the behavior of glomeru-
lar, tubular, and interstitial cells. This interaction between
infiltrating and resident cells leads to cellular proliferation,
matrix expansion, and may ultimately lead to glomerular
sclerosis and interstitial fibrosis.
 
1
 
Abbreviations used in this paper: 
 
CINC, cytokin-induced neutrophil
chemoattractant; GN, glomerulonephritis; IP-10, interferon-inducible
protein 10 kD; ISH, in situ hybridization; MCP-1, monocyte chemoat-
tractant protein-1; NSS, normal sheep serum; NTS, nephrotoxic serum;
RANTES, regulated upon activation in normal T cells expressed and se-
creted. 
 
This work was presented in part at the 29th Annual Meeting of the
American Society of Nephrology, New Orleans, Louisiana.
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Chemokines in Renal Inflammation and Fibrosis
 
Chemokines are a superfamily of small proteins that are im-
portant in recruiting and activating leukocytes during inflam-
mation (6). The chemokines RANTES (regulated upon
activation in normal T cells expressed and secreted) and
monocyte chemoattractant protein–1 (MCP-1) attract mainly
T lymphocytes and mononuclear phagocytes, respectively
(7, 8). In vivo, stimulated renal cells are capable of generat-
ing both of these chemokines (9, 10, 11), and both have
been found to be expressed during models of renal injury
(12, 13, 14). Several other chemokines including macro-
phage inflammatory protein-2 (MIP-2), platelet factor 4,
interferon-inducible protein 10 kD (IP-10), and cytokine-
induced neutrophil chemoattractant (CINC), have been
demonstrated to precede the initial neutrophil influx in ex-
perimental anti-GBM GN (15, 16). Studies with neutraliz-
ing antibodies show that inhibition of CINC, MIP-2, or
MCP-1/JE activity decreases neutrophil accumulation with
an associated decline in proteinuria during the first 24 h of
disease (17). However, all of these studies concentrate on
the acute phase of the disease occurring within the first 24 h
of the treatment. Moreover, all of these studies have fo-
cused on glomerular changes and do not explore the role
that interstitial cells are likely to play in the development of
disease throughout the whole cortex. Interstitial cells are
important mediators of inflammatory and fibrotic pathways,
and the factors that they secrete are likely to be integrally
involved in the development of pathology during nephritis
(18). Therefore, the in vivo role of chemokines in both
disease induction and development remains to be estab-
lished. In particular, the role of chemokines in the progres-
sion from inflammation to fibrosis is unclear.
In this study, we have developed and characterized a
murine model of accelerated nephrotoxic serum nephritis,
determined the nature of the leukocytic infiltration, and
analyzed the expression of chemokines during the progres-
sion of acute glomerular injury to glomerular crescent for-
mation and renal fibrosis. In addition, we have determined
the functional role of the 
 
b
 
 chemokines MCP-1 and
RANTES in the development of glomerular and interstitial
inflammation and crescent formation, as well as in the evo-
lution of the ensuing fibrosis.
 
Materials and Methods
 
Preparation of Nephrotoxic Serum.
 
Nephrotoxic serum (NTS)
was prepared by immunizing male sheep with a lysate of rat glom-
eruli, isolated by differential sieving as described previously (19).
The sheep serum was heat inactivated at 56
 
8
 
C, absorbed with rat
red blood cells and serum proteins, and then filter sterilized. As
reported elsewhere (20), NTS has moderate reactivity to type IV
collagen and laminin, and substantial reactivity to glomerular cell
membrane proteins, particularly 
 
b
 
1 integrin and its accompany-
ing 
 
a
 
 chain.
 
Induction of Crescentic Nephritis.
 
The protocol for inducing
crescentic glomerulonephritis in mice was that of Morley and
Wheeler (21), modified for our NTS to avoid rapid lethality from
acute renal failure while ensuring adequate tissue injury for analy-
sis. CD1 mice weighing 
 
z
 
30 g were pre-immunized by subcuta-
neous injection of 200 
 
m
 
g normal sheep IgG in Freund’s com-
plete adjuvant. After 5 d, experimental mice were injected
intravenously with 50 
 
m
 
l NTS on three consecutive days and
controls were injected with 50 
 
m
 
l normal sheep serum (NSS) on the
same schedule. At various intervals from 12 h to 3 wk after the
first dose of NTS, groups of 6 mice were killed by ether inhala-
tion after an overnight collection of urine in single animal metab-
olism cages. During this collection, mice were allowed free access
to water but not food. At the time of death, serum was obtained
by cardiac puncture, and portions of kidney were snap frozen for
immunohistology and RNA extraction, or fixed in 4% paraform-
aldehyde for in situ hybridization or in buffered formalin for rou-
tine histology.
 
Blocking Experiments.
 
Experiments were performed to modu-
late disease by the administration of mediators that neutralize or
modify chemokine function. Thus in separate experiments, groups
of mice (
 
n
 
 
 
5
 
 6) received daily intravenous doses of either the
RANTES antagonist, MetRANTES (22) or hamster anti-MCP-
1/JE (23) 30 min before administration of 50 
 
m
 
l of either NTS or
NSS. MetRANTES was administered at either 16 or 32 
 
m
 
g per
mouse per day, and anti–MCP-1/JE was given at 5 
 
m
 
g per mouse
per day. Controls included mice given sterile PBS or 5 
 
m
 
g normal
hamster immunoglobulin (Jackson ImmunoResearch Labs., West
Grove, PA), respectively. The blocking reagents were given to
mice in the stated doses from day 0 to day 6. Mice were then
killed on day 7, after 24 h in metabolic cages, and kidneys were
removed for morphological and immunohistological analyses, as
described below.
 
Morphological Analysis.
 
Kidney halves were fixed overnight at
4
 
8
 
C in 10% neutral buffered formalin (Fisher), embedded in par-
affin, sectioned at 3 
 
m
 
m and stained with hematoxylin and eosin fol-
lowing standard techniques. Sections from NTS mice were ex-
amined for glomerular hypercellularity and necrosis, mesangial
thickening, formation of glomerular crescents, interstitial infil-
trates, and development of glomerular and interstitial fibrosis, as
compared to NSS mice. A crescent score was obtained by count-
ing the number of glomeruli showing cellular crescents in at least
100 glomeruli per mouse.
 
Assessment of 24 h Proteinuria.
 
Urine protein excretion was
measured on timed overnight specimens collected at intervals from
3 d to 3 wk from individual mice in metabolism cages and assayed
by the sulphosalicylic method (19). Blood urea nitrogen was mea-
sured on 200-
 
m
 
l serum samples by the Boston University Medical
Center clinical laboratories using an auto-analyzer.
 
Immunohistochemical Phenotyping and Quantitation of Leuko-
cytes.
 
Kidneys from treated and untreated mice were excised,
rolled in Tissue Tek OCT compound (Cryoform, IEC, Needham,
MA) snap frozen in liquid nitrogen and stored at 
 
2
 
70
 
8
 
C. 4-
 
m
 
m
cryosections were cut onto microscope slides, air dried, and then
fixed in acetone at 4
 
8
 
C for 20 min. Fixed sections were stained
with rat monoclonal antibodies directed against Thy1 (T cells),
GR-1 (granulocytes) (both PharMingen, San Diego, CA) and
MOMA-2 (mononuclear phagocytes) (Biosource International, Ca-
marillo, CA) using an avidin/biotin staining method. All incuba-
tions were carried out under humidified conditions and slides were
washed twice between steps for 5 min each in 0.1 M PBS. First,
endogenous peroxidase was blocked by incubation for 20 min in
methanol containing 0.3% hydrogen peroxide. Nonspecific stain-
ing due to crossreaction with endogenous avidin or biotin was
then blocked by incubation with avidin solution followed by bi-
otin solution, both for 20 min (Vector, Burlingame, CA). There-
after, sections were overlaid with 20% normal rabbit serum in
PBS for 15 min and then incubated overnight at 4
 
8
 
C with mAbs
specific for either Thy1, MOMA-2, or GR-1 (all at 1/10 in 10% 
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normal mouse serum in PBS) (PharMingen). Bound monoclonal
antibody was visualized by incubation with biotinylated rabbit
anti–rat immunoglobulin diluted 1/200 in 10% normal mouse se-
rum in PBS, and then streptavidin peroxidase complex (prepared
according to manufacturer’s instructions) for 30 min each (both
Dako, Carpinteria, CA). Finally, slides were flooded with peroxi-
dase substrate solution (400 mg diaminobenzidine in 10 ml of
PBS, containing 0.01% hydrogen peroxide) for 10 min. Control
slides were included where monoclonal antibody, biotinylated
anti-rat immunoglobulin or streptavidin complex were selectively
omitted. All slides were counterstained with hematoxylin. For
each antibody the number of positively stained cells was deter-
mined in 15 high-power fields chosen at random per section
(40
 
3
 
 magnification; total area 1.8 mm
 
2
 
) and the average number
of cells/field was calculated for each mouse.
 
Measurement of mRNA Expression by Northern Blots.
 
Total RNA
from kidneys obtained from NTS- and NSS-treated mice was
isolated using the guanidinium thiocyanate/acid phenol proce-
dure (24). RNA was extracted from PBS-treated mice at the
same time points as NTS and NSS mice to determine basal levels
of chemokines. Northern blots (25) were prepared with 20 
 
m
 
g of
total RNA, purified as indicated above, fractionated in a 1.5%
agarose/formaldehyde gel and blotted onto a nylon membrane
(Genescreen, DuPont). Membranes were probed using 
 
32
 
P-labeled
probes for RANTES (26), MCP-1/JE (27), MIP-1
 
a
 
 (28), and
TCA-3 (29) applied in 50% formamide hybridization solution at
42
 
8
 
C for 18 h. Blots were washed in 2
 
3 
 
SSC/1%SDS at 45
 
8
 
C
and exposed at 
 
2
 
70
 
8
 
C on Kodak XAR5 film (Sigma).
 
Collagen I Deposition.
 
Samples of frozen kidney from NTS-
and NSS-treated mice were sectioned at 4 
 
m
 
m, washed in PBS,
fixed in acetone, and incubated with polyclonal rabbit anti–
mouse type I collagen (Chemicon International, Temecula, CA).
The primary antibody was detected with goat anti–rabbit IgG-
FITC (Jackson ImmunoResearch Labs.). Both the primary and
secondary antibodies were diluted to their optimal working con-
centration in 2% sheep IgG in PBS. The effectiveness of this
blocking procedure was confirmed by a negative staining reaction
when a non-specific normal rabbit serum was substituted for the
primary antibody. Tissues were also stained for sheep and mouse
IgG and mouse C3 using various commercially available FITC-
conjugated antisera. Sections were imaged using NIH image 1.56,
with 10 randomly chosen fields per section (at a magnification of
 
3
 
20) being screened to calculate the mean area stained for each
section.
 
Collagen I RNA Expression.
 
These studies used a 600-bp cDNA
probe that codes for the COOH terminus and a small part of the
untranslated region of the rat 
 
a
 
1 type I collagen gene (30) as pre-
viously described (31). The cDNA was inserted into and propa-
gated in a pBluescript vector (Stratagene) carrying flanking T3
and T7 RNA polymerase promoters. Once linearized, either of the
flanking RNA polymerase promoters could be employed to cre-
ate radioactively labeled sense or anti-sense riboprobes by a runoff
transcription method (25). Runoff transcription products were
hydrolyzed in 0.01 M DTT, 0.08 M NaHCO
 
3
 
, 0.12 M NaCO
 
3
 
for 60 min at 60
 
8
 
C and neutralized in 0.01 M DTT, 0.2 M Na
acetate, 0.17 M acetic acid. The product was recovered by salt–
ethanol precipitation and Sephadex G-50 chromatography (Phar-
macia, Piscataway, NJ). The fractions of interest were pooled, the
volume adjusted to give a final specific activity of 3 
 
3
 
 10
 
6
 
 cpm/
ml in 0.3 M DTT, and stored at 
 
2
 
70
 
8
 
C until used. Paraffin sec-
tions of 4-
 
m
 
m thickness were cut onto Superfrost
 
Ò
 
/Plus slides
(Fisher Scientific, Pittsburgh, PA), dewaxed, and hydrated. Pre-
hybridization, hybridization, and post-hybridization procedures
were carried out exactly as previously described (31). Finally, the
sections were coated with Kodak NTB-2 emulsion (Eastman Ko-
dak Co., Rochester, NY) and sealed in light-tight boxes at 4
 
8
 
C
for 7–14 d. The slides were developed with Kodak D-19 (East-
man Kodak Co.), counterstained with Mayer’s hematoxylin and
mounted using a water soluble mountant. Specificity was evalu-
ated by use of the sense riboprobe or by introduction of an
RNAse incubation step during the prehybridization. Sections
were examined and photographed with a Nikon Optiphot mi-
croscope equipped for dark-field illumination at 100
 
3
 
 magnifica-
tion and bright-field illumination at 100
 
3
 
 and 400
 
3
 
 magnifica-
tion (Nikon, Garden City, NY).
 
Statistical Analysis.
 
The significance of differences between
experimental groups was calculated by the Wilcoxon Mann-
Whitney test using Xlstat in Microsoft Excel 5.
 
Results
 
Morphological Changes in Renal Tissue.
 
The severity of glom-
erulonephritis  was dose dependent and varied from mild
glomerular hypercellularity to anuric acute renal failure and
early death from extensive glomerular necrosis and crescent
formation. There were no differences in histological ap-
pearance of kidneys from NSS mice compared with mice
given PBS only (Fig. 1 
 
A
 
). 12 h after the first injection of
NTS, proteinaceous casts were present in renal tubules, co-
incident with the onset of proteinuria. After 24 h, leuko-
cytes were evident within the interstitium and by day 3
prominent perivascular infiltrates were present (Fig. 1 
 
B
 
).
At this point the glomeruli were clearly hypercellular with
focal areas of necrosis. On day 5 some glomeruli contained
crescents and interstitial and perivascular infiltrates were
pronounced. On day 7, 55% of glomeruli exhibited promi-
nent cellular crescents (Fig. 1 
 
C
 
) and marked abnormalities
were present within the tubules and interstitium. These in-
cluded severely dilated tubules with flattened or denuded
epithelia and expansion of the interstitium due to edema,
interstitial infiltrates, and the onset of fibrosis (Fig. 1 
 
D
 
). On
day 14, the fibrotic process was more diffuse throughout
the interstitium and had extended to involve some of the
glomerular crescents, apparently by invasion through Bow-
man’s capsule.
 
Analysis of Renal Function.
 
Mice injected with NTS were
significantly proteinuric by day 3 and became progressively
more so throughout the course of the study (Fig. 2 
 
A
 
).
Blood urea nitrogen levels rose rapidly during the acute
phase of immunologic injury but then improved towards
baseline values over the course of 10 d (Fig. 2 
 
B
 
). How-
ever, concomitant with the development of progressive in-
terstitial and glomerular fibrosis, blood urea nitrogen levels
rose progressively from day 14.
 
Collagen I Expression.
 
Over the course of the disease,
both the interstitium and crescents became increasingly fi-
brotic as demonstrated by Masson trichrome staining (not
shown) and deposition of type I collagen (Fig. 3). Most
strikingly, a rapid induction of cells expressing mRNA for
 
a
 
1 type I collagen was seen by in situ hybridization (ISH)
in perivascular, periglomerular and intervening regions of
cortex within 3 d of the final injection of NTS (Fig. 3, 
 
A 
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and 
 
C
 
). These cells differed from those that constitutively
express 
 
a
 
1(I) collagen in the perivascular region of normal
and control mice and they progressively increased in num-
ber, intensity of signal, and extent over the course of dis-
ease. Immunofluorescent staining showed deposition of
collagen protein in corresponding areas (Fig. 3, 
 
B
 
 and 
 
D
 
).
Initially, glomeruli were negative for type I collagen by IF
and ISH, but with time (around day 14), 
 
a
 
1(I) mRNA-
positive cells encircling the glomeruli appeared to infiltrate
the Bowman’s capsule of some glomeruli and were fol-
lowed by positive IF staining of the crescents for type I col-
lagen (data not shown).
 
Characterization of Inflammatory Infiltrate.
 
Infiltrating lym-
phocytes, neutrophils and mononuclear phagocytes were
identified at different time points during the development
of crescentic GN by immunohistochemical staining of fro-
zen sections. (Fig. 4). Increases in both neutrophils and
mononuclear phagocytes, but not lymphocytes, were ob-
served 12 h after the first injection of NTS. However, by
day 3, all three cell types were increased in kidneys from
NTS mice when compared with those from NSS mice at
the same time period. Maximal numbers of neutrophils
were observed at day 3 of disease, whereas lymphocyte
numbers continued to be raised even at day 14. Peak mac-
rophage infiltration was seen at day 7 with a decline in num-
bers occurring by day 14.
 
Chemokine Expression.
 
Expression of chemokines involved
in the recruitment of leukocytes to sites of inflammation
was determined by Northern analysis of RNA isolated
throughout the development of crescentic GN (Fig. 5).
Therefore, mRNA expression for RANTES (CD4
 
1
 
 T cell
and eosinophil chemoattractant) (32); MCP-1/JE (mono-
cyte chemoattractant) (33); MIP-1
 
a
 
 (monocyte and eosin-
ophil chemoattractant) (28); and TCA3 (neutrophil and
monocyte chemoattractant) (23) was assessed. There was
no expression of either MCP-1/JE or RANTES at 12 or
24 h after the induction of disease, but from day 3 onwards
NTS treated mice showed strong expression of these che-
mokines,  whereas NSS- or PBS-treated mice did not.
There was no detectable expression of TCA-3 in either
NTS- or NSS-treated mice (data not shown). Low expres-
sion of MIP-1
 
a
 
 was detected in all mice, with no discern-
ible difference between mice from NTS or NSS groups.
 
Blocking Experiments with MetRANTES.
 
MetRANTES  was
used to neutralize the effect of this chemokine in order to
define the functional role that RANTES plays in the devel-
Figure 1. Administration of
nephrotoxic serum to pre-immu-
nized mice results in a severe
proliferative and necrotizing GN.
Hematoxylin and eosin staining
of kidney sections from mice
given either NSS (A) or NTS
(B–D). NTS mice showed glom-
erular and interstitial infiltrates
(B); glomerular crescent forma-
tion (C and D). Arrows highlight
crescentic glomeruli. Original
magnification: (A, B, and D)
340; (C) 320.1375 Lloyd et al.
opment of crescentic GN. Day 7 was chosen to determine
the effect of blocking RANTES as by this time there is a
significant infiltration by leukocytes, an increase in pro-
teinuria, and the beginning of the development of fibrosis, as
marked by collagen I deposition. Thus, 16 mg MetRANTES
was administered daily until day 6, when mice were housed
in metabolic cages for 24 h before killing on day 7. Four
disease parameters were then assessed for the effect of Met-
RANTES: 24 h proteinuria, leukocyte infiltration, glomerular
crescent formation and collagen deposition. First, Met-
RANTES was seen to induce a 36% decrease in excretion of
protein (31 6 5 mg/24 h in treated versus 52 6 7 mg/24 h in
untreated NTS mice, P ,0.05) (Fig. 6 A). In conjunction
with this there was a 52% decrease in numbers of T cells and
a 40% decline in mononuclear phagocyte numbers within
sections (P ,0.005). However, there was no difference in
numbers of neutrophils after MetRANTES treatment (Fig. 6
B). A 16% decrease in glomerular crescent formation was
counted in H&E stained sections (not significant), although
no other changes in morphological abnormalities was seen
to occur (Fig. 6 C). There was no difference in the deposition
of type I collagen after administration of MetRANTES (Fig. 6
D). This experiment was repeated with a higher dose of Met-
RANTES (32 mg/mouse/d) without additional benefit (data
not shown).
Figure 2. Nephrotoxic serum results in a decline in renal function. Re-
nal dysfunction in mice as shown by (A) proteinuria and (B) blood urea
nitrogen. Each point represents the mean values from either NSS (open cir-
cles, n 5 6) or NTS (closed circles, n 5 15) treated mice, and bars show the
standard error of the mean.
Figure 3. Nephrotoxic serum
induces expression of type I col-
lagen mRNA and protein. Dep-
osition of type I collagen in renal
tissue isolated from NSS (A and
B) or NTS (C and D) mice on
day 7 of crescentic GN. Plates
show (A and C) a 4-mm paraffin
section hybridized with a 35S-
cDNA probe encoding a region
of the at a1 type I collagen gene
and (B and D) a 4-mm frozen
section stained for mouse type I
collagen using indirect immuno-
fluorescence. G, glomerulus; *,
lumen of tubule; V, venule. Origi-
nal magnification 340.1376 Chemokines in Renal Inflammation and Fibrosis
Blocking Experiments with Anti–MCP-1/JE. A neutraliz-
ing monoclonal antibody specific for MCP-1/JE was used
to assess the contribution that this chemokine makes to the
development of crescentic GN. Experiments were con-
ducted exactly as described above for MetRANTES, with
5 mg of anti–MCP-1/JE or 5 mg hamster immunoglobulin
G (hIgG) being administered daily from day 0 to day 6 to
NTS or NSS mice. Hamster Ig had no effect upon the de-
velopment of disease. Proteinuria was seen to diminish by
25% upon administration of anti–MCP-1/JE (P ,0.01)
(Fig. 7 A). Immunohistochemical phenotyping revealed that
neutralizing MCP-1/JE resulted in a 47% decrease in mac-
rophages within both glomerular and the interstitial areas
(P ,0.05). Similarly, there was a decrease in numbers of
lymphocytes (P ,0.05). Interestingly, neutralizing MCP-
1/JE enhanced the increase in numbers of neutrophils, by
37% compared to untreated NTS mice (P ,0.01)(Fig. 7 B).
Interestingly there was a striking decrease (by 73.5%) in the
number of glomerular crescents on day 7 in treated mice com-
pared to untreated NTS mice (P ,0.001) (Fig. 7 C). Con-
comitant with this there was a 65% decrease in the deposition
of type I collagen in sections from anti–MCP-1–treated
NTS mice compared to untreated NTS mice (P ,0.005)
(Fig. 7 D).
Discussion
In this study we have investigated the role of chemo-
kines in the development of glomerular and interstitial in-
flammation and progression to renal fibrosis in a murine
model of crescentic glomerulonephritis. Glomerular and in-
terstitial hypercellularity are the earliest abnormalities in this
model of accelerated nephrotoxic serum nephritis (Fig. 1),
and they occur concomitantly with the appearance of se-
vere proteinuria and transient acute renal failure (Fig. 2). The
inflammatory infiltrate in glomeruli and interstitium is
composed of T-lymphocytes, mononuclear phagocytes and
neutrophils (Fig. 4), much as has been described in other
animal models of crescentic glomerulonephritis (34). Within
one week from the onset of disease, glomerular crescents
begin to form and there is perivascular and periglomerular
type I collagen gene induction (Fig. 3), signifying the onset
of renal fibrosis. PMNs, mononuclear phagocytes and lym-
phocytes may contribute to acute renal cell injury and pro-
gression of glomerular disease by a variety of different mecha-
nisms including inducing the secretion of pro-inflammatory
mediators such as TNFa and IL-1, which may then induce
chemokine expression by resident renal cells. The interac-
tion between infiltrating inflammatory cells and intrinsic
renal cells may lead to cell proliferation and matrix expan-
sion which would ultimately result in glomerulosclerosis
and interstitial fibrosis.
To determine the role of chemokines in eliciting the mi-
gration of inflammatory cells to the kidney in this model,
we first examined their expression during the evolution of
the lesion and then established the functional role of likely
candidates with blocking agents. RANTES and MCP-1 are
strongly expressed after disease induction (Fig. 5) at a time
Figure 4. Nephrotoxic serum induces an increase in numbers of leuko-
cytes within renal tissue. Sections were prepared from NSS (open circles) or
NTS (closed circles) mice at various times after disease induction and stained
with antibodies specific for T-lymphocytes (a), mononuclear phagocytes
(b), and neutrophils (c). Positively stained cells were counted in 15 high
power fields per section (total area 5 0.5mm2). Each dot represents one
individual mouse analyzed (between 3 and 10 mice per group) with bars
depicting means for each group.
Figure 5. Kidneys from mice with crescentic nepritis show expression
of inflammatory chemokines. Northern blot analysis was performed using
total RNA (20 mg) extracted from kidneys isolated from NSS or NTS
mice throughout disease. Expression of two representative mice at each
time point is included. Expression of b-actin was used to determine the
quality and quantity of RNA.1377 Lloyd et al.
that coincides with the influx of T-lymphocytes and mono-
nuclear phagocytes, and that follows the earlier appearance
of neutrophils. MIP1a was found to be constitutively ex-
pressed in the kidney and was not upregulated during cres-
centic nephritis. We did not see any expression of TCA3
during crescentic nephritis, but this may reflect the re-
stricted secretion profile of this particular chemokine (23).
MCP-1 and RANTES are both critical mediators in the
evolution of inflammatory reactions and are known to be
secreted by isolated resident renal cells in vitro (11, 17, 26)
as well as by infiltrating inflammatory cells. Expression
of both RANTES and MCP-1 has been documented in
several human nephritides (35) as well as during experi-
mental anti-GBM GN (14, 17) but these studies are limited
to examining glomerular changes occurring during a rela-
tively short time period and do not provide evidence that
chemokines are involved in the development of inflamma-
tion and disease progression. In our study however, admin-
istration of a RANTES antagonist resulted in a decrease in
the accumulation of T cells and monocytes/macrophages
concomitant with a partial attenuation of proteinuria (Fig. 6).
MetRANTES is a functional antagonist of RANTES and
blocks calcium mobilization as well as chemotaxis of T cells
and monocytes (22). Interestingly, MetRANTES antago-
Figure 6. MetRANTES reduces proteinuria and mononuclear cell in-
filtration. The effects of the RANTES antagonist MetRANTES on de-
velopment of (A) proteinuria, (B) leukocyte infiltration, (C) glomerular
crescent formation, and (D) deposition of type I collagen is shown.
Groups of NSS (open circles, n 5 3) and NTS (closed circles, n 5 6) mice
given 16 mg/day of MetRANTES or PBS were scarified on day 7 of dis-
ease. For A, C, and D, each point represents one mouse and bars indicate
the mean for each group. For B, numbers of T-lymphocytes (T), mono-
nuclear phagocytes (M) and granulocytes (G) were enumerated in immu-
nohistochemically stained sections and bars represent the standard error of
the mean for each group. Positively stained cells were counted within the
glomeruli (open bars) and interstitium (shaded bars) of 15 randomly chosen,
high power fields within each section. For C, one hundred glomeruli were
counted in a hematoxylin and eosin-stained section from each mouse, and
the percentage of glomeruli containing cellular crescents was calculated.
In D, kidney sections were stained with an antibody against type I col-
lagen, which was detected with a fluoresceinated secondary antibody.
Distribution of immunofluorescence was measured in 10 random fields
from each section using NIH image 1.56. For each panel the significance
of differences between treated and untreated groups of NTS mice were
determined by a Wilcoxon Mann-Whitney test.
Figure 7. Antibodies to MCP-1 reduce proteinuria and mononuclear
cell infiltration, as well as glomerular crescent formation and collagen
deposition. The effects of neutralizing antibodies to MCP-1/JE on (A)
proteinuria, (B) leukocyte infiltration, (C) glomerular crescent formation,
and (D) deposition of type I collagen are shown. Groups of NSS (open cir-
cles, n 5 4) and NTS (closed circles, n 5 10) were treated daily with 5 mg/d
hamster anti–mouse MCP-1/JE or hamster immunoglobulin and were
then killed on day 7 of disease. For A, C, and D, each point represents
one mouse and bars indicate the mean for each group. For B, numbers of
T-lymphocytes (T), mononuclear phagocytes (M), and granulocytes (G)
were enumerated in immunohistochemically stained sections and bars
represent the standard error of the mean for each group. Positively stained
cells were counted within the glomeruli (open bars) and interstitium
(shaded bars) of 15 randomly chosen, high power fields within each sec-
tion. For C, 100 glomeruli were counted in a hematoxylin and eosin-
stained section from each mouse, and the percentage of glomeruli con-
taining cellular crescents was calculated. In D, kidney sections were
stained with an antibody against type I collagen that was detected with a
fluoresceinated secondary antibody. Distribution of immunofluorescence
was measured in 10 random fields from each section using NIH image
1.56. For each panel the significance of differences between treated and
untreated groups of NTS mice were determined by a Wilcoxon Mann-
Whitney test.1378 Chemokines in Renal Inflammation and Fibrosis
nizes RANTES and MIP-1a with equal potency in chemo-
taxis assays but not calcium mobilization. It is thought to
act as a competitive inhibitor on the shared MIP-1a/
RANTES receptor. We did not find increased expression of
MIP-1a in our model of crescentic GN and therefore as-
sume that Met-RANTES is acting primarily to antagonize
RANTES, thereby partially blocking the in vivo migration
of T cells and mononuclear phagocytes. We have also shown
that inhibition of MCP-1 by administration of neutralizing
antibodies results in decreased accumulation of mono-
nuclear phagocytes and T-lymphocytes, concomitant with
a partial attenuation of proteinuria (Fig. 7). Thus, we have
shown that both MCP-1 and RANTES are critically involved
in the primary inflammatory phase of crescentic GN.
Progression of disease in mice with crescentic GN was
marked by the development of glomerular crescents and the
deposition of type I collagen within the interstitium. We
have examined the role that MCP-1 and RANTES play in
the progression to this later stage of disease. Although ad-
ministration of a RANTES antagonist resulted in a de-
crease in the accumulation of T cells and monocytes/mac-
rophages, there was little effect on glomerular crescent
formation or deposition of interstitial type I collagen. Pre-
vious studies have suggested that activated periglomerular
T cells may be involved in the disruption of Bowman’s
capsule (36), and CD81 T cell depletion has been found to
inhibit crescent formation, (37), but we have shown that
RANTES does not appear to be involved in this process.
Conversely, neutralizing antibodies to MCP-1 resulted in a
striking decrease in both glomerular crescent formation and
collagen I deposition. It is interesting that although mac-
rophage accumulation was only inhibited by 50% by anti-
body administration, this decrease is sufficient to cause such
an impressive effect on markers of fibrosis. Since mono-
cyte/macrophage accumulation was not completely inhib-
ited by MCP-1 neutralization, it seems likely that other
macrophage-specific chemokines may contribute to this
migration. It is not inconceivable that MCP-1 not only af-
fects migration and extravasation of mononuclear phago-
cytes but mediates direct effects upon the resident renal
cells, which in turn affects the pathway to fibrosis. MCP-1
may participate in this fibrotic process directly, by inducing
the secretion of extracellular matrix components, or indi-
rectly by instigating the secretion of other pro-fibrotic me-
diators. It is also possible that MCP-1 alters the phenotype
of resident renal cells leading to parietal glomerular epithe-
lial cell proliferation, collagen I production by interstitial fi-
broblasts, or even tubular epithelial cell transmodulation
(38, 39). Whether this is a direct effect of MCP-1, or is
mediated by other fibrogenic agents such as TGF-b,
PDGF, or FGF, has yet to be determined. We have prelim-
inary data demonstrating the expression of TGF-b mRNA
in murine crescentic glomerulonephritis (data not shown),
however despite its well-established fibrogenic properties
(40), the functional role of this cytokine in post-inflamma-
tory interstitial fibrosis of the kidney has yet to be docu-
mented. It is noteworthy that the mice in our model are
heavily proteinuric, which some have suggested may be a
sufficient stimulus for renal tubular chemokine production
and consequent interstitial inflammation and fibrosis (41).
On the other hand, proteinuria in the absence of accompa-
nying glomerular inflammation does not appear to stimu-
late MCP-1 expression (41).
This work has centered on characterizing a murine
model of crescentic nephritis and determining the role of
the b chemokines MCP-1 and RANTES in the renal in-
flammation, crescent formation and in the development of
the ensuing interstitial fibrosis. We can conclude that both
chemokines play a role in the influx of inflammatory cells
to the glomeruli and interstitium and in the initial develop-
ment of renal dysfunction. Moreover, MCP-1 seems to
play a critical role in the development of the characteristic
glomerular crescents and in the deposition of type I col-
lagen. It is likely that this chemokine mediates direct effects
upon intrinsic renal cells which ultimately leads to the for-
mation of crescents and secretion of matrix components.
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